Lineage Announces Initiation of Development Activities for Hypoimmune Pluripotent Cell Line for Neurology Indications Under Partnership With Eterna Therapeutics
Lineage Cell Therapeutics, Inc. ; class='js-l-obf link link--blue'
Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lineage Cell Therapeutics, Inc. ; class='js-l-obf link link--blue'
(RTTNews) - Shares of Nykode Therapeutics ASA were gaining around 4 percent in the morning trading in Norway after the company announced that the ...
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 Lausanne, Switzerland, September 05, 2023 – AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on...
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20. OSLO, Norway, Sept. 05, 2023 (GLOBE NEWSWIRE)